Harrington Scholar-Innovator Awards

Harrington Scholar-Innovator Awards is sponsored by Harrington Discovery Institute at University Hospitals. Supports breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, and infectious diseases.

Drug Discovery and Developing Funding for Physician Scientists and Basic Research for Medicine | Harrington Scholar-Innovator | Harrington Discovery Institute at University Hospitals Harrington Scholar-Innovator Call Opens for Applications Application Submission Deadline Finalists Contacted for Due Diligence Review Announce 2027 Scholar-Innovators This scholar award recognizes outstanding physician-scientists whose work has potential to advance standard of care.

Each year up to 12 Harrington Scholar-Innovators are chosen.

The award includes: $100,000 guaranteed grant award Opportunity to compete for acceleration funds up to $300,000 Opportunity to qualify for investment funds typically up to $2MM A personalized team of drug developers and project manager for each award recipient Expert business, commercialization and clinical development advice Intellectual property (IP) review and advice Assistance identifying and securing additional financial support based on project needs MD or MD/PhD (or equivalent) Faculty position at an accredited academic medical center, university or research institution in the US or Canada, and conduct the majority of his/her/their research at that institution A project must have a single Principal Investigator (PI), who is responsible for project oversight and financial management.

The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project. Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects. Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute’s submission system.

Proposals received after the deadline will not be reviewed.

The Harrington Scholar-Innovator award selection committee seeks breakthrough discoveries defined by innovation, creativity and potential for clinical impact, including: Discoveries deemed to address unmet medical needs Modulators of novel targets Potential to be developed into a commercial program Strong intellectual property (IP) or protection strategy May be a small molecule, biologic, or other therapeutic modality Diagnostics or devices should be part of a therapeutic development project “The Harrington program is invaluable, not just because of the financial support of our research project, but the tutorial, the teaching and the mentorship...

Harrington really helped me communicate the clinical need from the patient's perspective, the market and basically gave me all the tools to start talking to investors." 2014 Harrington Scholar-Innovator “Working with our Harrington team, there have been more than one 'why didn't I think of that?' moments."

Director, Krembil Research Institute University of Toronto University Health Network 2020 Harrington Scholar-Innovator “Our Harrington advisors are insightful and brilliant scientists." 2021 Harrington Scholar-Innovator “Harrington is committed to helping us find answers. They share our curiosity."

Distinguished Professor of Surgery University of California, Davis 2022 Harrington Scholar-Innovator “Without question, the monthly advisory meetings have sharpened our focus and expedited the pace of our progress.

” Professor, Pediatrics, Harvard Medical School Professor, Pediatric Oncology, Chemical Biology Dana-Farber Cancer Institute 2022 Harrington Scholar-Innovator “Harrington is very much a hybrid between the best of academia and the best of industry.

It gives you access to the best of the medical industry with excellent consultants and project managers who have brought products to market, combined with the risk-taking of academia." 2023 Harrington Scholar-Innovator “Harrington connects me with experts who can give me direct feedback from a pharmaceutical company's leadership perspective, which is very useful."

Department of Cancer Immunology and Virology Dana-Farber Cancer Institute 2023 Harrington Scholar-Innovator